SPY Technical Analysis and GEX Option Insights: February 6, 2025

246
Technical Analysis:
1. Current Price Action:
* SPY is trading near $604.74, showing a breakout attempt.
* Immediate resistance is at $609.96 (today's high), while strong support lies near $600.00.
* The symmetrical triangle formation suggests a potential continuation, with volume confirming bullish momentum.

2. Indicators:
* MACD: Bullish crossover indicates upward momentum, but a flattening signal line warrants caution.
* Stochastic RSI: Overbought levels near 99, signaling possible consolidation or pullback.
* Volume: Increasing volumes support upward movement but require sustained buying pressure to confirm the breakout.

3. Trend Lines:
* Upside potential toward $615.00 (2nd Call Wall) if SPY clears $610.00.
* Breakdown below $600.00 could revisit $595.00.

Gamma Exposure (GEX) Insights:
snapshot
1. Key GEX Levels:
* Call Resistance: $610.00 and $615.00 are major resistance zones.
* Put Support: $600.00 (strong gamma hedge zone) and $595.00 (critical floor).

2. Options Sentiment:
* GEX: Dominated by 68.5% puts, signaling hedging at lower levels but potential for squeeze if buyers persist.
* IVR/IVx: 15.5% IVR, indicating options are relatively inexpensive, suitable for directional plays.
* Skew: High put open interest suggests a bearish skew, but a breakout could trigger a gamma squeeze.

Trade Setup Suggestions:
1. Bullish Scenario:
* Entry: Above $610.00.
* Targets: $615.00, $620.00.
* Stop-Loss: $600.00.

2. Bearish Scenario:
* Entry: Below $600.00.
* Targets: $595.00, $590.00.
* Stop-Loss: $610.00.

Thoughts:
* SPY shows bullish potential but is overextended short-term.
* A confirmed breakout above $610.00 could lead to a gamma squeeze toward $615.00+.
* Failure to sustain above $600.00 may invite sellers to retest lower supports.

Disclaimer:
This analysis is for educational purposes only and does not constitute financial advice. Please conduct your research and risk management before making trading decisions.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.